|Product Name||Description||Catalog #|
|MAT-Test Kit*||96 well test plate**||CTL-MAT-001|
Quality without compromise
Each component of the CTL-MAT test kit is fine tuned for optimal performance, and thoroughly quality controlled for such. These kits have been formulated to achieve high reactivity and sensitivity.
Reactivity and sensitivity of CTL-MAT. Typical LPS dose response curve is shown after testing with CTL-MAT Kit. LPS was titrated in the concentration range specified on the X axis. The concentration of IL-6 detected in the culture supernatant after 20 h incubation of the PBMC with LPS is shown on the Y axis. Note the high reactivity, and sensitivity.
The indicator PBMC have been frozen according to Ph. Eur. 2.6.30 according to proprietary protocols that assure that the cryopreserved cells maintain their full functionality after freeze thawing (see representative data below). CTL-MAT offers PBMC suited for MAT testing also independent of its kits, from single donors or pools of 4 or 8 donors.
European Pharmacopeia 2.6.30 specifies requirements for PBMC to be used in MAT. The PBMC provided in CTL-MAT Kits fulfill the mandated criteria:
Intra-batch reproducibility of CTL-MAT results. Four CTL-MAT kits from a single production batch were tested in four independent assays. The PBMC were aliquots of the same pool of 4 donors (Vials 1 -4, specified by symbols). LPS was titrated in the concentration range specified on the X axis. The concentration of IL-6 detected in the culture supernatant after 20 h incubation of the PBMC with LPS is shown on the Y axis. Note the overlapping curves, showing high intra-batch reproducibility of results obtained with CTL MAT kits.
In addition to the 8-donor PBMC pools that are included in the CTL-MAT kits, we also offer Ph. Eur. 2.6.30 compliant, or R&D grade PBMC independently. These are available from single donors, or pools of 4 or 8 donors. Each batch is tested for MAT performance after freezing as part of our quality control procedure.
|Product Name||Description||Unit size||Catalog #|
|MAT-PBMC||Ph. Eur. 2.6.30 compliant, 8 donor pool||1 vial, 5 mio PBMC/vial||CTL-MAT-PE8|
|MAT-PBMC||Ph. Eur. 2.6.30 compliant, 4 donor pool||1 vial, 5 mio PBMC/vial||CTL-MAT-PE4|
According to Ph. Eur. 2.6.30, each product must be tested in order to conclude whether and how it may interfere with the MAT system itself. Our team can help you with every step of the validation process.
MAT BioTech B.V. | Hollandse Kade 32-33 | 1391 JM Abcoude | The Netherlands
MAT BioTech 2019
All Rights Reserved - Privacy Statement